Fu, Zheng-Qi <br/><br/>
LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro.  [electronic resource] 

 -  Journal of Alzheimer's disease : JAD  2010 
 - 1107-17 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1875-8908 
<br/><br/><label>Standard No.: </label>10.3233/jad-2010-100687  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Coculture Techniques<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>HEK293 Cells<br/>Humans<br/>Lithium Chloride--pharmacology<br/>Male<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Thapsigargin--antagonists & inhibitors<br/>tau Proteins--metabolism